Literature DB >> 23940964

[Effects of ropivacaine on GABA-activated currents in isolated dorsal root ganglion neurons in rats].

Yue Yang1, Jun-Qiang Si, Chao Fan, Ke-Tao Ma, Hong-Jv Cheng, Li Li.   

Abstract

OBJECTIVE: To investigate the effects of ropivacaine on Gamma-aminobutyric acid(GABA)-activated currents in dorsal root ganglion (DRG) neurons in rats and discuss the analgesia mechanism of ropivacaine.
METHODS: By means of using whole-cell patch-clamp technique, to investigate the modulatory effects of ropivacaine on GABA-activated currents (I(GABA)) in acutely isolated dorsal root ganglion neurons.
RESULTS: (1) In 48 out of 73DRG cells (65.7%, 48/73), to perfusion ropivacaine bromide (0.1 - 1 000 micromol/L) were sensitive. Which produce in 0 to 380 pA current. (2) The majority of the neurons examined (74.5%, 73/98) were sensitive to GABA. Concentration of 1 - 1 000 micromol/L GABA could activate a concentration-dependent inward current, which manifested obvious desensitization, and the inward currents could be blocked byGABA-receptor selective antagonist of bicuculline (100 micromol/L). (3) After the neurons were treated with ropivacaine (0.1 - 1000 micromol/L) prior to the application of GABA (100 micromol/L) 30 s, GABA currents were obviously increased. Ropivacaine could make dose-response curve of the GABA up, EC50 is 23.46 micromol/L. Ropivacaine shifted the GABA dose-response curve upward and increased the maximum response to the contrast about 153%.
CONCLUSION: The enhancement of ropivacaine to DRG neurons activation of GABA current, can lead to enhancement of pre-synaptic inhibition at the spinal cord level. This may be one of the reasons for the anesthetic effect and analgesia for ropivacaine in epidural anesthesia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23940964

Source DB:  PubMed          Journal:  Zhongguo Ying Yong Sheng Li Xue Za Zhi        ISSN: 1000-6834


  1 in total

Review 1.  Synthesis and biological activities of local anesthetics.

Authors:  Shiyang Zhou; Gangliang Huang; Guangying Chen
Journal:  RSC Adv       Date:  2019-12-13       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.